http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1861381-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2006-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aeb3be49f9b5862d7f712f860c7fad7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a633994c580fdbfb1169f3838d774688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87779a8ee811d4b4dad1532a5f9718ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b45e603f28f6acab75d4f73df8b9d1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c868d9e56b821c33d7da6774853accb |
publicationDate | 2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1861381-A1 |
titleOfInvention | Novel 3-aryl-1,2-benzisoxazole derivatives, compostions containing same and use thereof |
abstract | The invention concerns novel products of formula (I), wherein: A1 and A2 represent CH or N; X represents Cra or N; Y represents CRb or N; R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB> and R<SUB>4</SUB> identical or different represent in particular hydrogen, halogen, cyano, nitro, trifluoromethyl, OR<SUB>5</SUB>, SR<SUB>5</SUB>, NR<SUB>5</SUB>R<SUB>6</SUB>, C(O)R<SUB>5</SUB>, C(O)OR<SUB>5</SUB>, C(O) NR<SUB>5</SUB>R<SUB>6</SUB>, S(O)R<SUB>5</SUB>, S(O)<SUB>2</SUB>R<SUB>5</SUB>, S(O)NR<SUB>5</SUB>R<SUB>6</SUB>, S(O)<SUB>2</SUB>NR<SUB>5</SUB>R<SUB>6</SUB>, NR<SUB>6</SUB>C(O)R<SUB>5</SUB>, NR<SUB>6</SUB>C(O)OR<SUB>5</SUB>, alkyls, alkenyls, alkynyls, aryls, heteroaryls, aralkyls or heteroaralkyls, all optionally substituted; Ra represents in particular halogen, hydroxyl, alkoxy, nitro; Rb represents in particular hydrogen, halogen, cyano, nitro, trifluoromethyle, -W-(C<SUB>1</SUB>- C<SUB>3</SUB> alkyl)m- R<SUB>5</SUB>; R<SUB>5</SUB> and R<SUB>6</SUB> represent in particular alkyl, aralkyl or heteroaralkyls optionally substituted; said products being all in the form of isomers and salts, and their use as medicines. |
priorityDate | 2005-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 395.